Clinical testing of the smartphone based device for early cervical cancer diagnosis
Not Applicable
- Conditions
- Health Condition 1: B977- Papillomavirus as the cause of diseases classified elsewhere
- Registration Number
- CTRI/2022/02/040066
- Lead Sponsor
- PhotoSpIMeDx Private Limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Women patients who visit the OPD and have symptoms or not of cervical cancer.
Exclusion Criteria
No criteria
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The outcome of study is the fluorescence signal captured from the patients that provide the biochemical changes happening inside the tissues during cancer progression. The fluorescence signal captures the changes of certain biomarkers which are present intrinsically such as FAD, Porphyrin, NADH etc. There concentration changes as as the cancer progresses inside the human.Timepoint: The outcome of the study will be assessed after every 4 weeks from the date of trials start.
- Secondary Outcome Measures
Name Time Method ot applicableTimepoint: Not applicable